This document provides a list of publications by Jan VAN LOO related to prebiotics and their effects. It includes 28 publications from 2001-2009 covering topics such as:
- Effects of prebiotic supplementation on stool metabolites and gut microbiota in senior cats.
- Prebiotics supporting the growth of probiotic bacteria in vitro.
- Prebiotics modulating markers of tumor progression in human colon tumor cells.
- Synbiotic consumption modulating cancer risk biomarkers in human subjects.
- Prebiotic treatment decreasing colon carcinogenesis in rats.
- Prebiotics having potential anticarcinogenic activities when evaluated in human volunteers.
Dr. Tom Burkey - Host-Microbe Interactions: Effects on nutrition and physiologyJohn Blue
Host-Microbe Interactions: Effects on nutrition and physiology - Dr. Tom Burkey, University of Nebraska-Lincoln, from the 2014 Allen D. Leman Swine Conference, September 15-16, 2014, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2014-leman-swine-conference-material
This document discusses the potential for developing localized probiotic formulations tailored to specific geographic regions and populations. It notes key differences in gut microbiota composition and dietary habits between regions that could impact probiotic efficacy. Specific needs in developing nations like vitamin production and diarrhea prevention are also addressed. The document advocates considering how probiotics might survive locally consumed foods and addresses technological advances that could aid rational probiotic selection based on regional diets and health issues.
1) The document discusses the potential benefits of probiotics for the elderly population and summarizes several studies that have investigated the effects of various probiotic strains on the gut microbiota and immune system of elderly subjects.
2) It then outlines objectives and methodology for a proposed clinical study to investigate the influence of the probiotic Lactobacillus helveticus MTCC 5463, delivered through a synbiotic dairy product, on the gut microbiota and health of geriatric volunteers.
3) The study will involve collecting fecal samples and blood to analyze changes in gut microflora composition, biochemical activities, and hematological and immunological parameters before and after consumption of the synbiotic product.
This document provides recommendations from Cynthia Belew, CNM, WHNP-C on strategies to support the microbiome in women's healthcare. Key recommendations include educating patients on fiber and fermented foods, using probiotics judiciously based on evidence, decreasing antibiotic use by only prescribing when clinically indicated, and engaging in shared decision-making for GBS prophylaxis. The document emphasizes viewing the gut microbiome as integral to human health and considers ways to minimize disruptions during pregnancy and childbirth.
Renée Wilson, Registered Dietitian and PhD Candidate at University of Otago, New Zealand. Presented at the 1st International Symposium on Kiwifruit and Health: http://www.kiwifruitsymposium.org/presentations/diet-microbiota-and-metabolic-health/
This cross-sectional pilot study aims to determine whether or not there are any differences between the gut microbiota of people with normal glucose tolerance, pre-diabetes and type 2 diabetes.
The UNL Gut Function Initiative studies the complex ecosystem of the vertebrate gut. It aims to understand how host tissues, microbiota, diet, and other factors influence gut health and disease. Key areas of focus include identifying microbes that promote gut health, studying host-microbe interactions, and using quantitative genetics to find host genes that control gut microbiota composition. Findings could translate to developing prebiotics, anti-microbials, and markers for selective breeding to improve animal agriculture and human health. A current project examines if genetic predisposition affects E. coli colonization in cattle.
This document discusses the potential role of enteroviruses, especially coxsackievirus B, in the development of type 1 diabetes mellitus (T1DM). It provides evidence from various studies that enteroviruses may infect and damage pancreatic beta cells, triggering an immune response and autoimmunity. While several viruses have been linked to T1DM, data implicates enteroviruses most strongly. The document also discusses potential mechanisms of viral persistence and the idea that enterovirus infection could initiate cycles of autoimmunity through presentation of viral and self-antigens.
The document summarizes the development of intestinal microbiota from infancy to adulthood. It describes how acquisition begins at birth and is influenced by maternal and environmental factors. The infant microbiota develops successively, influenced by factors like breastfeeding, antibiotics, and diet. During the first year, the microbiota plays a pivotal role in immune system maturation. In adulthood, the microbiota is impacted by lifestyle, medications, diet, stress, age, and living situation. Changes in the elderly microbiota can induce inflammation. Location of residence in the elderly is correlated with microbiota composition and health markers.
Dr. Tom Burkey - Host-Microbe Interactions: Effects on nutrition and physiologyJohn Blue
Host-Microbe Interactions: Effects on nutrition and physiology - Dr. Tom Burkey, University of Nebraska-Lincoln, from the 2014 Allen D. Leman Swine Conference, September 15-16, 2014, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2014-leman-swine-conference-material
This document discusses the potential for developing localized probiotic formulations tailored to specific geographic regions and populations. It notes key differences in gut microbiota composition and dietary habits between regions that could impact probiotic efficacy. Specific needs in developing nations like vitamin production and diarrhea prevention are also addressed. The document advocates considering how probiotics might survive locally consumed foods and addresses technological advances that could aid rational probiotic selection based on regional diets and health issues.
1) The document discusses the potential benefits of probiotics for the elderly population and summarizes several studies that have investigated the effects of various probiotic strains on the gut microbiota and immune system of elderly subjects.
2) It then outlines objectives and methodology for a proposed clinical study to investigate the influence of the probiotic Lactobacillus helveticus MTCC 5463, delivered through a synbiotic dairy product, on the gut microbiota and health of geriatric volunteers.
3) The study will involve collecting fecal samples and blood to analyze changes in gut microflora composition, biochemical activities, and hematological and immunological parameters before and after consumption of the synbiotic product.
This document provides recommendations from Cynthia Belew, CNM, WHNP-C on strategies to support the microbiome in women's healthcare. Key recommendations include educating patients on fiber and fermented foods, using probiotics judiciously based on evidence, decreasing antibiotic use by only prescribing when clinically indicated, and engaging in shared decision-making for GBS prophylaxis. The document emphasizes viewing the gut microbiome as integral to human health and considers ways to minimize disruptions during pregnancy and childbirth.
Renée Wilson, Registered Dietitian and PhD Candidate at University of Otago, New Zealand. Presented at the 1st International Symposium on Kiwifruit and Health: http://www.kiwifruitsymposium.org/presentations/diet-microbiota-and-metabolic-health/
This cross-sectional pilot study aims to determine whether or not there are any differences between the gut microbiota of people with normal glucose tolerance, pre-diabetes and type 2 diabetes.
The UNL Gut Function Initiative studies the complex ecosystem of the vertebrate gut. It aims to understand how host tissues, microbiota, diet, and other factors influence gut health and disease. Key areas of focus include identifying microbes that promote gut health, studying host-microbe interactions, and using quantitative genetics to find host genes that control gut microbiota composition. Findings could translate to developing prebiotics, anti-microbials, and markers for selective breeding to improve animal agriculture and human health. A current project examines if genetic predisposition affects E. coli colonization in cattle.
This document discusses the potential role of enteroviruses, especially coxsackievirus B, in the development of type 1 diabetes mellitus (T1DM). It provides evidence from various studies that enteroviruses may infect and damage pancreatic beta cells, triggering an immune response and autoimmunity. While several viruses have been linked to T1DM, data implicates enteroviruses most strongly. The document also discusses potential mechanisms of viral persistence and the idea that enterovirus infection could initiate cycles of autoimmunity through presentation of viral and self-antigens.
The document summarizes the development of intestinal microbiota from infancy to adulthood. It describes how acquisition begins at birth and is influenced by maternal and environmental factors. The infant microbiota develops successively, influenced by factors like breastfeeding, antibiotics, and diet. During the first year, the microbiota plays a pivotal role in immune system maturation. In adulthood, the microbiota is impacted by lifestyle, medications, diet, stress, age, and living situation. Changes in the elderly microbiota can induce inflammation. Location of residence in the elderly is correlated with microbiota composition and health markers.
This document provides biographical and professional information about Xingdong Yang. It includes his education, research experiences, publications, technical skills, patents, and grant writing experience. The key points are:
- Xingdong Yang received his Ph.D. in Virology and Immunology from Virginia-Maryland College of Veterinary Medicine. He is currently a postdoctoral research fellow at Cleveland Clinic.
- His research focuses on developing adoptive immunotherapy for cancer using IL9-producing NK cells and stem cell-like NK cells.
- He has over 15 peer-reviewed publications related to his work studying viral pathogenesis and immune responses using neonatal gnotobiotic pig models.
- He has experience in vi
The document discusses insights from nutrigenomics research on how diet shapes our health. It makes three key points:
1) Our "paleolithic" hunter-gatherer genes interact with modern diets high in processed foods and lack of challenges from varied whole foods. This mismatch may contribute to disease.
2) Components in plant foods like fibers can have anti-inflammatory effects and influence the gut microbiome in ways that promote health. Dietary challenges from varied whole foods that activate genes like PPARg are more beneficial than safe but nutritionally "empty" processed foods.
3) The gut microbiome plays an important role in mediating the effects of diet on health and disease. For example
Bacteriological quality and safety of street vended foods in delta state, nig...Alexander Decker
This study analyzed 106 street food samples from 9 towns in Delta State, Nigeria for bacterial contamination. All food
samples showed some level of bacterial contamination, with counts ranging from 1.2 x 102 to 1.1 x 107 cfu/g. 69% of
samples exceeded the acceptable limit of <104 cfu/g for total bacterial count. Total coliform counts ranged from 36 to
2100 MPN/g, with 67% of samples exceeding the recommended limit of <100 MPN/g. Nine bacterial species were
isolated, including pathogens like E. coli, S. aureus, Salmonella spp. More than one pathogen was found in foods like
fufu, o
Diet Dominates Host Genotype in Shaping the Murine Gut MicrobiotaAlireza Kashani
Diet has a significant impact on shaping the gut microbiota composition according to this study. Researchers found that placing mice on different diets (low-fat vs high-fat/high-sugar) caused their gut microbiota to cluster more by diet than by host genotype. Even for mice with the same genotype, diet dominated in determining microbiota profile. When diets were alternated, the microbiota responded rapidly but showed some lag effects. The study demonstrates the outsized role of diet relative to host genetics in shaping the gut microbiome.
This document discusses the relationship between nutritional status and pressure ulcers. It provides epidemiological data showing that malnutrition is associated with increased risk of developing pressure ulcers. Experimental studies in animals also demonstrate impaired wound healing in malnourished subjects. However, clinical studies on the effect of nutritional supplementation on pressure ulcer prevention and treatment have shown mixed results, with some finding no effect of supplementation on ulcer outcomes. Overall, while malnutrition and pressure ulcers often coexist, the relationship is complex and a causal link has not been firmly established.
The document summarizes research into the relationship between gut bacteria, bile acids, and cancer risk. Researchers believe that an imbalance in gut bacteria from conditions like diabetes or a Western diet can increase toxic bile acids, raising cancer risk. The researchers aim to determine bacteria's role in gastrointestinal and liver cancers and whether restoring bacterial balance through probiotics can prevent cancer. They will test if a gut bacterium and milk sugars can lower cancer risk by enriching good bacteria, reducing inflammation and toxic bile acids.
This study examined the gut microbiota in a mouse model of autism spectrum disorder (ASD) and found abnormalities in gastrointestinal function and behavior. Treatment with the probiotic Bacteroides fragilis corrected gastrointestinal deficits, improved behavioral symptoms, and normalized metabolite levels. This suggests a connection between the gut microbiome and brain in neurodevelopmental disorders, and that probiotic therapy may help treat symptoms.
An Ecophylogenetic Approach to Determine the Evolutionary History of the Mamm...tsharpton
Identifying those gut microbes that co-diversify with mammals is important to our understanding of the mechanisms and health implications of host-microbiome interactions. For example, microbiota that are conserved across mammalian species may express a trait that has been subject to selection throughout the evolution of these mammals, possibly because it is critical to health. While advances in environmental DNA sequencing have transformed our understanding of how enteric microbes are distributed across mammalian species, these data are frequently analyzed using phylogenetically agnostic approaches. Such approaches can obscure the detection of diverged groups of bacteria that have been conserved across mammalian species. To provide enhanced resolution into evolutionary associations between gut microbiota and mammals, we innovated a high-throughput ecophylogenetic method, known as ClaatTU (Cladal Taxonomic Units). ClaaTU analyzes phylogenies assembled from environmental DNA sequences collected from a set of microbial communities and profiles the presence and abundance of each monophyletic clade in each community. As a result, it enables the identification of specific microbial clades that are distributed across host communities in a manner indicative of being associated with mammalian evolution. To demonstrate this, we applied ClaaTU to a mammalian microbiome dataset and (1) identified clades of gut bacteria that are unique to groups of mammals based on their taxonomy or dietary regime, (2)
found that there exists ecophylogenetic structure in the mammalian gut microbiome, indicating that gut bacterial phylogenetic diversity associates with host phylogeny, and
(3) discovered specic clades that are present in a larger number of mammals than expected by chance, some of which may co-diversify with their hosts. Our findings indicate that some mammalian gut microbiota may have been anciently acquired and subsequently retained in extant lineages, indicating that they may play an important role in mediating host-microbiome interactions and maintaining host health.
The gut microbiota refers to the complex community of bacteria in the intestine. Its composition is initially determined at birth by factors like delivery method and feeding, and later by medications, sanitation, diet, and environment. Animal models have shown that genetic, dietary, and environmental influences can alter the gut microbiota. Studies have linked the human gut microbiome to type 2 diabetes, finding that diet influences its composition and that certain bacterial signatures in the gut promote intestinal inflammation and systemic inflammation linked to type 2 diabetes. Gastric bypass surgery, which highly effectively treats obesity and type 2 diabetes, likely works through changes to diet and the gut microbiota.
Human Gut Mycobiota is still a mistery for us. Most of the reasearch on this topichas been conducted in the last 5 years. We are starting to comprehend the interactions with our gastrointestinal system and the virus and bacterial communities. 13% of gut microbiota in weight, about 150 species; most of them can shift from commensalism to virulent parassitosis according to our immune competence. Gut fungal overgrowth is actually underestimated in dignaosis and treatment. Many FGIDS and SIBO are frequently mixed bacteral and fungal dysbiosis
This document is a dedication and acknowledgments section from a thesis. It dedicates the thesis to the author's family and thanks various individuals and institutions for their support and contributions to completing the work. It expresses gratitude to God, the author's parents, the thesis advisor, various doctors and laboratories, secretaries, statisticians, participating subjects, and the Faculty of Medicine for their help and assistance during the research and writing process.
Human nutrition, gut microbiome and immune system S'eclairer
Dr Zahida Chaudnary talks with the students about nutrition, gut microbiomes, and nutrition as we look at diseases and how your body reacts to what you eat.
Check out the slideshow by itself here.
Want an audio version? Subscribe to our Podcast on iTunes!
Want to join us for the live discussion? Check out our Social Media in the noon hour every Monday as we sit down on Google Hangout OnAir! Follow us on Twitter, Facebook, or Google+ to get updated with the link when we start!
- Diet, physical exercise, and other factors can shape the composition of the human gut microbiome. A diet high in microbiota-accessible carbohydrates promotes a diverse microbiome that supports metabolic health. Physical exercise is also able to modify the gut microbiota in beneficial ways. Visceral fat accumulation has been linked to the microbiome, and diet and microbiota may synergistically impact host visceral fat mass. Recommendations include consuming a diet rich in fibers, vitamins, and minerals that require gut microbiota to aid absorption.
Patologie digestive, extradigestive e MicrobiotaASMaD
The document discusses the human microbiome and its role in various gastrointestinal diseases. It begins by noting that the microbiome contains over 1000 bacterial species and 1 million genes, far more than the human genome. It then discusses how the microbiome is established during birth and early life, and how it varies over time and geography. The document also explores how dysbiosis, or imbalance of the microbiome, is associated with diseases like IBD, IBS, diverticular disease, obesity and metabolic syndrome. It presents evidence that fecal microbiota transplantation can treat diseases like C. difficile infection and metabolic syndrome. Finally, it discusses potential therapeutic approaches like prebiotics, probiotics, antibiotics and diet to treat dysbiosis
Moving into the Post-MetagenomicEra of Gut Microbiome ResearchJonathan Clarke
Julian Marchesi's presentation slides from our previous Microbiome R&D and Business Collaboration Forum. For information about this years event please visit http://www.globalengage.co.uk/microbiota.html
El lunes 23 de octubre de 2017 celebramos una jornada en la Fundación Ramón Areces sobre Microbiota Intestinal: Implicaciones en la Salud y Enfermedad.
Increase your Understanding of the Pathogenesis of Gluten Spectrum DisordersCell Science Systems
Recently, researchers at Harvard University, Alessio Fasano et. al., and the National Institutes of Health (laboratories of immunology and cellular and molecular biology), reported real-time microscopic observations of gluten-induced neutrophil activation.
According to authors, " To what extent neutrophil function adds to, or protects against, gluten intolerance is currently under vigorous investigation."
This presentation will shed light on this question. It will also review the Fasano study and examine the role of neutrophil function in multiple disease conditions, as well as explore how neutrophil function may also play a dual role in protecting the body from the untoward effects of dietary and environmental agents.
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...ueda2015
The document discusses the role of gut microbiota in the pathogenesis of obesity and type 2 diabetes mellitus (TDM2). It provides an introduction to gut microbiota, symbiotic relationships, evidence connecting gut microbiota to obesity and TDM2, and potential mechanisms of causality. Key points include that gut microbiota composition differs between obese and lean individuals, transplantation studies show gut microbiota can influence weight gain, and mechanisms may involve energy harvest from food, production of short chain fatty acids, effects on hormones like GLP-1, and low-grade inflammation from bacterial translocation.
The document discusses gut microbiota and various techniques used to study it. It begins by describing the importance of gut microbiota in digestion, development of the immune system, maintenance of the intestinal barrier, and health and disease. It then covers culture-based and molecular-based techniques used to characterize gut microbiota, including their pros and cons. Specific molecular techniques discussed include FISH, DNA microarrays, DGGE/TGGE, 454 pyrosequencing, and quantitative PCR. The document also addresses pitfalls of molecular techniques and provides examples of studies comparing the gut microbiota of normal vs. diseased horses.
This document discusses the use of probiotics in the neonatal intensive care unit (NICU) to help prevent diseases like necrotizing enterocolitis (NEC). It provides background on the development of the infant gut microbiome and how probiotics may benefit preterm infants by competing with pathogens, producing antimicrobial substances, and modulating the immune system. Several studies cited found probiotic supplementation significantly reduced the risk of NEC and mortality in very low birth weight infants. Meta-analyses support the routine use of probiotics in the NICU.
This document lists Petra Roubos' publications, including 10 full papers published in peer-reviewed journals on topics related to microbiology and intestinal health. It also lists 7 conference papers presented between 2013-2015 related to microbiota, intestinal barrier function, and diarrhea in pigs. The list covers publications in book chapters and as lead author and co-author.
This document provides biographical and professional information about Xingdong Yang. It includes his education, research experiences, publications, technical skills, patents, and grant writing experience. The key points are:
- Xingdong Yang received his Ph.D. in Virology and Immunology from Virginia-Maryland College of Veterinary Medicine. He is currently a postdoctoral research fellow at Cleveland Clinic.
- His research focuses on developing adoptive immunotherapy for cancer using IL9-producing NK cells and stem cell-like NK cells.
- He has over 15 peer-reviewed publications related to his work studying viral pathogenesis and immune responses using neonatal gnotobiotic pig models.
- He has experience in vi
The document discusses insights from nutrigenomics research on how diet shapes our health. It makes three key points:
1) Our "paleolithic" hunter-gatherer genes interact with modern diets high in processed foods and lack of challenges from varied whole foods. This mismatch may contribute to disease.
2) Components in plant foods like fibers can have anti-inflammatory effects and influence the gut microbiome in ways that promote health. Dietary challenges from varied whole foods that activate genes like PPARg are more beneficial than safe but nutritionally "empty" processed foods.
3) The gut microbiome plays an important role in mediating the effects of diet on health and disease. For example
Bacteriological quality and safety of street vended foods in delta state, nig...Alexander Decker
This study analyzed 106 street food samples from 9 towns in Delta State, Nigeria for bacterial contamination. All food
samples showed some level of bacterial contamination, with counts ranging from 1.2 x 102 to 1.1 x 107 cfu/g. 69% of
samples exceeded the acceptable limit of <104 cfu/g for total bacterial count. Total coliform counts ranged from 36 to
2100 MPN/g, with 67% of samples exceeding the recommended limit of <100 MPN/g. Nine bacterial species were
isolated, including pathogens like E. coli, S. aureus, Salmonella spp. More than one pathogen was found in foods like
fufu, o
Diet Dominates Host Genotype in Shaping the Murine Gut MicrobiotaAlireza Kashani
Diet has a significant impact on shaping the gut microbiota composition according to this study. Researchers found that placing mice on different diets (low-fat vs high-fat/high-sugar) caused their gut microbiota to cluster more by diet than by host genotype. Even for mice with the same genotype, diet dominated in determining microbiota profile. When diets were alternated, the microbiota responded rapidly but showed some lag effects. The study demonstrates the outsized role of diet relative to host genetics in shaping the gut microbiome.
This document discusses the relationship between nutritional status and pressure ulcers. It provides epidemiological data showing that malnutrition is associated with increased risk of developing pressure ulcers. Experimental studies in animals also demonstrate impaired wound healing in malnourished subjects. However, clinical studies on the effect of nutritional supplementation on pressure ulcer prevention and treatment have shown mixed results, with some finding no effect of supplementation on ulcer outcomes. Overall, while malnutrition and pressure ulcers often coexist, the relationship is complex and a causal link has not been firmly established.
The document summarizes research into the relationship between gut bacteria, bile acids, and cancer risk. Researchers believe that an imbalance in gut bacteria from conditions like diabetes or a Western diet can increase toxic bile acids, raising cancer risk. The researchers aim to determine bacteria's role in gastrointestinal and liver cancers and whether restoring bacterial balance through probiotics can prevent cancer. They will test if a gut bacterium and milk sugars can lower cancer risk by enriching good bacteria, reducing inflammation and toxic bile acids.
This study examined the gut microbiota in a mouse model of autism spectrum disorder (ASD) and found abnormalities in gastrointestinal function and behavior. Treatment with the probiotic Bacteroides fragilis corrected gastrointestinal deficits, improved behavioral symptoms, and normalized metabolite levels. This suggests a connection between the gut microbiome and brain in neurodevelopmental disorders, and that probiotic therapy may help treat symptoms.
An Ecophylogenetic Approach to Determine the Evolutionary History of the Mamm...tsharpton
Identifying those gut microbes that co-diversify with mammals is important to our understanding of the mechanisms and health implications of host-microbiome interactions. For example, microbiota that are conserved across mammalian species may express a trait that has been subject to selection throughout the evolution of these mammals, possibly because it is critical to health. While advances in environmental DNA sequencing have transformed our understanding of how enteric microbes are distributed across mammalian species, these data are frequently analyzed using phylogenetically agnostic approaches. Such approaches can obscure the detection of diverged groups of bacteria that have been conserved across mammalian species. To provide enhanced resolution into evolutionary associations between gut microbiota and mammals, we innovated a high-throughput ecophylogenetic method, known as ClaatTU (Cladal Taxonomic Units). ClaaTU analyzes phylogenies assembled from environmental DNA sequences collected from a set of microbial communities and profiles the presence and abundance of each monophyletic clade in each community. As a result, it enables the identification of specific microbial clades that are distributed across host communities in a manner indicative of being associated with mammalian evolution. To demonstrate this, we applied ClaaTU to a mammalian microbiome dataset and (1) identified clades of gut bacteria that are unique to groups of mammals based on their taxonomy or dietary regime, (2)
found that there exists ecophylogenetic structure in the mammalian gut microbiome, indicating that gut bacterial phylogenetic diversity associates with host phylogeny, and
(3) discovered specic clades that are present in a larger number of mammals than expected by chance, some of which may co-diversify with their hosts. Our findings indicate that some mammalian gut microbiota may have been anciently acquired and subsequently retained in extant lineages, indicating that they may play an important role in mediating host-microbiome interactions and maintaining host health.
The gut microbiota refers to the complex community of bacteria in the intestine. Its composition is initially determined at birth by factors like delivery method and feeding, and later by medications, sanitation, diet, and environment. Animal models have shown that genetic, dietary, and environmental influences can alter the gut microbiota. Studies have linked the human gut microbiome to type 2 diabetes, finding that diet influences its composition and that certain bacterial signatures in the gut promote intestinal inflammation and systemic inflammation linked to type 2 diabetes. Gastric bypass surgery, which highly effectively treats obesity and type 2 diabetes, likely works through changes to diet and the gut microbiota.
Human Gut Mycobiota is still a mistery for us. Most of the reasearch on this topichas been conducted in the last 5 years. We are starting to comprehend the interactions with our gastrointestinal system and the virus and bacterial communities. 13% of gut microbiota in weight, about 150 species; most of them can shift from commensalism to virulent parassitosis according to our immune competence. Gut fungal overgrowth is actually underestimated in dignaosis and treatment. Many FGIDS and SIBO are frequently mixed bacteral and fungal dysbiosis
This document is a dedication and acknowledgments section from a thesis. It dedicates the thesis to the author's family and thanks various individuals and institutions for their support and contributions to completing the work. It expresses gratitude to God, the author's parents, the thesis advisor, various doctors and laboratories, secretaries, statisticians, participating subjects, and the Faculty of Medicine for their help and assistance during the research and writing process.
Human nutrition, gut microbiome and immune system S'eclairer
Dr Zahida Chaudnary talks with the students about nutrition, gut microbiomes, and nutrition as we look at diseases and how your body reacts to what you eat.
Check out the slideshow by itself here.
Want an audio version? Subscribe to our Podcast on iTunes!
Want to join us for the live discussion? Check out our Social Media in the noon hour every Monday as we sit down on Google Hangout OnAir! Follow us on Twitter, Facebook, or Google+ to get updated with the link when we start!
- Diet, physical exercise, and other factors can shape the composition of the human gut microbiome. A diet high in microbiota-accessible carbohydrates promotes a diverse microbiome that supports metabolic health. Physical exercise is also able to modify the gut microbiota in beneficial ways. Visceral fat accumulation has been linked to the microbiome, and diet and microbiota may synergistically impact host visceral fat mass. Recommendations include consuming a diet rich in fibers, vitamins, and minerals that require gut microbiota to aid absorption.
Patologie digestive, extradigestive e MicrobiotaASMaD
The document discusses the human microbiome and its role in various gastrointestinal diseases. It begins by noting that the microbiome contains over 1000 bacterial species and 1 million genes, far more than the human genome. It then discusses how the microbiome is established during birth and early life, and how it varies over time and geography. The document also explores how dysbiosis, or imbalance of the microbiome, is associated with diseases like IBD, IBS, diverticular disease, obesity and metabolic syndrome. It presents evidence that fecal microbiota transplantation can treat diseases like C. difficile infection and metabolic syndrome. Finally, it discusses potential therapeutic approaches like prebiotics, probiotics, antibiotics and diet to treat dysbiosis
Moving into the Post-MetagenomicEra of Gut Microbiome ResearchJonathan Clarke
Julian Marchesi's presentation slides from our previous Microbiome R&D and Business Collaboration Forum. For information about this years event please visit http://www.globalengage.co.uk/microbiota.html
El lunes 23 de octubre de 2017 celebramos una jornada en la Fundación Ramón Areces sobre Microbiota Intestinal: Implicaciones en la Salud y Enfermedad.
Increase your Understanding of the Pathogenesis of Gluten Spectrum DisordersCell Science Systems
Recently, researchers at Harvard University, Alessio Fasano et. al., and the National Institutes of Health (laboratories of immunology and cellular and molecular biology), reported real-time microscopic observations of gluten-induced neutrophil activation.
According to authors, " To what extent neutrophil function adds to, or protects against, gluten intolerance is currently under vigorous investigation."
This presentation will shed light on this question. It will also review the Fasano study and examine the role of neutrophil function in multiple disease conditions, as well as explore how neutrophil function may also play a dual role in protecting the body from the untoward effects of dietary and environmental agents.
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...ueda2015
The document discusses the role of gut microbiota in the pathogenesis of obesity and type 2 diabetes mellitus (TDM2). It provides an introduction to gut microbiota, symbiotic relationships, evidence connecting gut microbiota to obesity and TDM2, and potential mechanisms of causality. Key points include that gut microbiota composition differs between obese and lean individuals, transplantation studies show gut microbiota can influence weight gain, and mechanisms may involve energy harvest from food, production of short chain fatty acids, effects on hormones like GLP-1, and low-grade inflammation from bacterial translocation.
The document discusses gut microbiota and various techniques used to study it. It begins by describing the importance of gut microbiota in digestion, development of the immune system, maintenance of the intestinal barrier, and health and disease. It then covers culture-based and molecular-based techniques used to characterize gut microbiota, including their pros and cons. Specific molecular techniques discussed include FISH, DNA microarrays, DGGE/TGGE, 454 pyrosequencing, and quantitative PCR. The document also addresses pitfalls of molecular techniques and provides examples of studies comparing the gut microbiota of normal vs. diseased horses.
This document discusses the use of probiotics in the neonatal intensive care unit (NICU) to help prevent diseases like necrotizing enterocolitis (NEC). It provides background on the development of the infant gut microbiome and how probiotics may benefit preterm infants by competing with pathogens, producing antimicrobial substances, and modulating the immune system. Several studies cited found probiotic supplementation significantly reduced the risk of NEC and mortality in very low birth weight infants. Meta-analyses support the routine use of probiotics in the NICU.
This document lists Petra Roubos' publications, including 10 full papers published in peer-reviewed journals on topics related to microbiology and intestinal health. It also lists 7 conference papers presented between 2013-2015 related to microbiota, intestinal barrier function, and diarrhea in pigs. The list covers publications in book chapters and as lead author and co-author.
Preventive role of probiotics to face SARS-CoV-2 pandemicHussein Al-tameemi
This document discusses probiotics and their potential preventive role against SARS-CoV-2. It defines probiotics as live microorganisms that provide health benefits when consumed. Common probiotic genera include Lactobacillus, Bifidobacterium, and Enterococcus. Probiotics may have antiviral effects through producing inhibitory substances, direct interaction with viruses, and stimulating the immune system. Studies have found probiotics can reduce severity of respiratory, GI, and other viral infections. The document recommends consuming probiotic foods during the SARS-CoV-2 pandemic and establishing guidelines for their use.
This document provides 63 bibliographic references on topics related to nutrition and its effects on the skin, hair, and overall health. The references cover research on fatty acids like omega-3 and their anti-inflammatory properties. Other topics discussed include the roles of vitamins D and B12, minerals like calcium and iron, and supplements like coenzyme Q10. The references were published between 1961 and 2016 in academic journals and cover clinical trials, case studies, and literature reviews.
The document discusses digestive well-being and probiotics. It begins with an introduction to the topic, noting that one-third to one-half of the population suffers from digestive illnesses related to diet and lifestyle. It then covers the roles of probiotics and normal gut flora in supporting metabolic processes, epithelial cell differentiation, and pathogen protection. Probiotics, including lactobacilli and bifidobacteria, are live microorganisms that can beneficially affect the host by improving gut microbial balance. Prebiotics are non-digestible foods that stimulate the growth of beneficial bacteria. Clinical studies have shown probiotics may help maintain optimal mucosal barrier function and balance intestinal flora.
'Lo último en obesidad'. Este es el título del Simposio Internacional que organizamos en la Fundación Ramón Areces los días 1 y 2 de diciembre de 2015. En colaboración con la Fundación General CSIC, reunió a algunos de los mayores expertos en la materia para analizar cómo reducir este grave problema de salud pública.
Food allergy has been long recognized and well documented. Other adverse reactions to foods first referred to as “toxic idiopathies” by John Freeman, co inventor of immunotherapy, at the early part of the 1900s can be mediated by and have their impact on the nervous and endocrine systems. It can also be mediated by pharmacologic mechanisms and can also affect any part of the body. There’s a great clinical need to accurately identify triggers of adverse reactivity as they have now been linked with even the most serious of modern maladies and diseases. In fact, inflammation is the hallmark of metabolic syndrome. Given the multitude of pathogenic mechanisms underlying adverse reactions to foods and other environmental exposures it is necessary that a utilizable and cost effective technology be understood so that its application be utilized under the appropriate circumstances.
KEY LEARNING POINTS
• The natural ability of certain foods to initiate an inflammatory response and induce metabolic disruptions and counterbalancing mechanisms to prevent that
• How foods can trigger “danger signals” for the immune system
Pharmacologic vs. immunologic reactions to foods
• Is there a common final pathway of all these mechanisms that can reliably indicate triggers of clinical pathology?
• Cellular testing vs. serologic testing: The advantages of cellular testing
This document discusses probiotics, which are live microorganisms that provide health benefits when consumed. Probiotics include Lactobacillus, Bifidobacterium, and others. They survive stomach acid and reside in the intestines, where they may competitively exclude pathogens, enhance immune response, and produce fatty acids. Probiotics are generally safe but can cause minor side effects and rarely serious infections. They are available as foods and supplements and may be useful for various health conditions.
An excellent blend of fresh mint pineapple tasting supplement, providing several health maintenance and disease prevention ingredients based on scientific data available only from Richard Clement Nutrition.
Manufactured in the USA in a GMP plant
This document discusses the role of probiotics in adult gastroenterology. It provides a brief history of probiotics dating back to Elie Metchnikof in 1908. Probiotics are defined as live microorganisms that provide health benefits when consumed. The gut microbiota plays an important role in health, and probiotics may help treat or prevent conditions caused by microbial imbalances like infectious diarrhea, irritable bowel syndrome, inflammatory bowel disease, obesity, and liver diseases. Probiotics have demonstrated benefits, but their effects tend to be strain-specific and more research is still needed, especially for conditions like Crohn's disease. Safety concerns also exist for certain at-risk populations.
This document is a curriculum vitae for Lei Li, a professor at the State Key Laboratory of Stem Cell and Reproductive Biology at the Chinese Academy of Sciences. It outlines her education, degrees, professional experience, awards, publications, and invited presentations. She received her PhD from Gunma University in Japan and has held positions at several institutions in China, Japan, and the United States. Her research focuses on early mouse embryonic development and diabetes.
This document discusses Helicobacter pylori infection. It begins with a summary of the discovery of H. pylori, including Giulio Bizzozero's initial description in 1892 and Robin Warren and Barry Marshall's cultivation of H. pylori in 1982. It then covers the epidemiology of H. pylori infection, indications for treatment, methods for diagnosing infection, treatments for infection, and the role of H. pylori eradication in preventing gastric cancer. Key points include that over 50% of the world's population is infected with H. pylori and treatment aims to cure ulcers and reduce cancer risk. Diagnosis involves non-invasive tests like serology or breath tests
Ellen Kamhi PhD RN, Research validation of the Role of Intestinal Permeability in the Inflammatory Process, also called LEAKY GUT SYNDROME, along with Studies on the use of Natural Therapies for this condition
Sub-clinical necrotic enteritis: its aetiology and predisposing factors in co...Chamari Palliyeguru
How does the multi-factorial disease sub-clinical necrotic enteritis induced in poultry fed without antibiotic growth promoters?
Clostridium perfringes a commensal bacterium on the large intestines, induces enteritis and necroses in upper intestines.
Many dietary and management stress factors affect the multiplication of bacteria in the upper intestines. Thus, causes a severe damage in the absorptive mucosae causing a significant loss in the growth performances.
Impact of gut microbes on gastrointestinal diseaseSandra Unorji
Gut microbes have been identified play a role in both health and disease. Surprisingly, we are outnumbered by them which raises questions that has led to several research with interesting results.
This study investigated using bacteriophage therapy to treat cholera. A single bacteriophage, Phi_1, was found to effectively control cholera in an infant rabbit model when given prophylactically or therapeutically, with phage-treated animals showing no clinical signs of disease. No phage-resistant bacterial mutants were found in the animals despite extensive searching. This provides the first evidence that a single phage could treat cholera without detectable resistance and suggests clinical trials in humans should be considered.
1) Dietary supplements like glucosamine, chondroitin sulfate, vitamins, omega-3 fatty acids, and herbal extracts are commonly used to treat osteoarthritis (OA) symptoms, but their efficacy is unclear due to a lack of conclusive evidence.
2) Nutrigenomics research aims to define how genes and nutrients interact to influence health and disease, with the goal of developing personalized nutrition plans.
3) Curcumin and resveratrol show potential for treating OA by reducing inflammation and suppressing cartilage degradation, but more research is still needed, including well-designed clinical trials.
The laboratory focuses on developing drug delivery systems using biomaterials like hyaluronic acid. A thermosensitive injectable hydrogel was created using nanocomplexes of doxorubicin and hyaluronic acid for local cancer treatment. This hydrogel inhibited cancer cell growth and selectively targeted the lymphatic system due to hyaluronic acid's affinity for the lymphatic system. The lab is also exploring combination therapy delivery systems, such as a thermosensitive hydrogel incorporating doxorubicin and docetaxel-loaded nanoparticles for overcoming drug resistance in tumors.
Genetics of Obesity: The thrifty gene hypothesisStephen Magness
Early humans faced regular cycles of feast and famine that promoted the evolution and selection of "thrifty genes" that increased the body's ability to efficiently store and utilize fuels like fat and glucose. While these genes provided an evolutionary advantage in the past by helping humans survive periods of starvation, they predispose modern humans to obesity and related diseases due to our current environment of abundant food and low physical activity levels. The "thrifty genotype" hypothesis has been expanded to include the concept of a "thrifty epigenome," where environmental factors like famine experienced by pregnant mothers can epigenetically influence gene expression and metabolic function in offspring in ways that increase disease risk in a modern context of plentiful food.
Invited lectures, presentations and publicationsOlga Pulido
This document lists invited lectures, publications, and research presentations by the author from 2000 to the present. It focuses on topics related to toxicology pathology, including harmful algal blooms, celiac disease, neurotoxicology, food allergens and excitotoxins, marine biotoxins, and the role of pathology in regulatory toxicology. Many of the presentations and publications were invited works in international forums on topics pertaining to the health effects of environmental and food toxins.
1. Jan VAN LOO
PAPERS
REFERENCE
PUBLICATION
YEAR
Fructan supplementation of senior cats affects stool metabolite
concentrations and fecal microbiota concentrations, but not nitrogen
partitioning in excreta.
Barry KA, Hernot DC, Van Loo J, Fahey GC Jr, de Godoy MR.
J Anim Sci. 2014 Nov;92(11):4964-71. doi: 10.2527/jas.2013-7510. 2014
Van Loo J, “Natural selection” Position paper on Clean Lable. In International
Ingredient Magazine (Nov 2013). 2013
Rurangwa E; Laranja J L; Van HouR; DelaeY; Geraylou Z; Van de Wiele T;
Van loo J; Van Craeyveld V; Courtin C M; Delcour J A; Ollevier F (2009)
Selected nondigestible carbohydrates and prebiotisupport the growth of
probiotic fish bacteria mono-cultures in vitro.
Journal of applied microbiology, vol 106 (3); pp 932-940 2009
Inflammatory disease processes and interactions with nutrition
Calder, P. C.; Albers, R.; Antoine, J.-M.; Blum, S.; Bourdet-Sicard, R.;
Ferns, G. A.; Folkerts, G.; Friedmann, P. S.; Frost, G. S.; Guarner, F.;
Lovik, M.; MacFarlane, S.; Meyer, P. D.; M'Rabet, L.; Serafini, M.; van
Eden, W.; van loo, J.; Vas Dias, W.; Vidry, S.; Winklhofer-Roob, B. M.;
British Journal of Nutrition (2009), 101(Suppl. 1), S1/T,S1/TC,S1-S45 2009
Prebiotiand animal nutrition
Van loo, Jan; Vancraeynest, Dieter
ORAFTI, Tienen, Belg.
Handbook of Prebioti(2008), 421-436. Editor(s): Gibson, Glenn R.;
Roberfroid, Marcel B. Publisher: CRC Press, Boca Raton, Fla.
CODEN: 69KMMX; ISBN: 978-0-8493-8171-3
DOI 10.1201/9780849381829.ch21
Conference; General Review 2008
Bosscher, Douwina; Van loo, Jan (2008) Oligofructose -enriched inulin :
keeping optimal body weight
Nutrafoods vol 7; pp 21-25 2008
Inulin-type fructans
Van loo, Jan; Bosscher, Douwina
BENEO-Orafti, Tienen, B3300, Belg.
Therapeutic Microbiology (2008), 147-157. Editor(s): Versalovic, James;
Wilson, Michael. Publisher: American Society for Microbiology,
Washington,
D. C.
CODEN: 69LALZ; ISBN: 978-1-55581-403-8
Conference; General Review 2008
Oligofructose-enriched inulin: keeping optimal body weight Bosscher,
Douwina; Van loo, Jan BENEO-Orafti, Tienen, Belg. Nutrafoods (2008),
7(1), 21-25 2008
2. Dietary synbiotireduce cancer risk factors in polypectomized and colon
cancer patients
Rafter, Joseph; Bennett, Michael; Caderni, Giovanna; Clune, Yvonne;
Hughes, Roisin; Karlsson, Pernilla C.; Klinder, Annett; O'Riordan,
Micheal; O'Sullivan, Gerald C.; Pool-Zobel, Beatrice; Rechkemmer,
Gerhard;
Roller, Monika; Rowland, Ian; Salvadori, Maddalena; Thijs, Herbert; Van
Loo, Jan (Reprint); Watzl, Bernhard; Collins, John K.
AMERICAN JOURNAL OF CLINICAL NUTRITION, (FEB 2007) Vol. 85, No. 2,
pp.
488-496.
ISSN: 0002-9165. 2007
How chicory fructans contribute to zootechnical performance and well-being
in livestock and companion animals
Van loo, Jan
ORAFTI, Tienen, B3300, Belg.
Journal of Nutrition (2007), 137(11S), 2594S-2597S
CODEN: JONUAI; ISSN: 0022-3166 2007
Inulin and oligofructose as prebiotiin the prevention of intestinal
infections and diseases
Bosscher, D.; Van loo, J.; Franck, A.
ORAFGroup, Tienen, B-3300, Belg.
Nutrition Research Reviews (2006), 19(2), 216-226 2006
Inulin and oligofructose as functional ingredients to improve bone
mineralization
Bosscher, D.; Van loo, J.; Franck, A.
Tiense Suikerraffinaderij, Orafti, Tienen, 3300, Belg.
International Dairy Journal (2006), 16(9), 1092-1097 2006
Inulin and oligofructose in lowering the risk of osteoporosis: a major
concern for women's health
Bosscher, Douwina; Van loo, Jan; Franck, Anne
Orafti, Tienen, B3300, Belg.
Agro Food Industry Hi-Tech (2006), 17(1), 10-12 2006
Prebiotic Synergy1 (oligofructose enriched inulin) reduces risk factors
for osteoporosis
Van loo J (Reprint); Bosscher D; Franck A
ORAFTI, Nutr Res, B-3300 Tienen, Belgium
CYA Belgium
FASEB JOURNAL, (7 MAR 2006) Vol. 20, No. 5, Part 2, pp. A1064-A1064. 2006
Experimental modulation of cancer risk factors by prebiotic oligofructose
enriched inulin (Synergy1) is confirmed in human volunteers Van loo J
(Reprint); Bosscher D; Franck A ORAFTI, B-3300 Tienen, BelgiumCYA
Belgium FASEB JOURNAL, (7 MAR 2006) Vol. 20, No. 5, Part 2, pp. A994-
A994. 2006
3. On the use of prebiotic food ingredient Synergy1 (Oligofructose enriched
inulin) in the management of inflammatory bowel disease
Van loo J (Reprint); Bosscher D; Franck A; Guarner F
ORAFTI, B-3300 Tienen, Belgium; Hosp Gen Valle Hebron, Digest Syst Res
Unit, Barcelona 08035, Spain
CYA Belgium; Spain
FASEB JOURNAL, (7 MAR 2006) Vol. 20, No. 5, Part 2, pp. A989-A989. 2006
Human evolution, nutritional ecology and prebiotiin ancient diet
Leach, Jeff D.; Gibson, Glenn R.; Van loo, Jan
School of Archaeology & Ancient History, University of Leicester,
Leicester, LE1 7RH, UK
Bioscience and Microflora (2006), 25(1), 1-8 2006
Inulin and oligofructose: in the prevention of osteoporosis
Bosscher, Douwina; Van loo, Jan; Franck, Anne
Orafti, Tienen, B3300, Belg.
Nutrafoods (2005), 4(2/3), 69-73 2005
Prebiotic oligofructose-enriched chicory inulin combination with
probiotics: in the prevention of colon cancer in experimental models and
human volunteers
Van loo, Jan; Clune, Yvonne; Bosscher, Douwina; Franck, Anne
OrafGroup, Tienen, B3300, Belg.
Agro Food Industry Hi-Tech (2005), 16(4), 6-8 2005
The SYNCAN project: goals, set-up, first results and settings of the human
intervention study
Van loo J (Reprint); Clune Y; Bennett M; Collins J K
BRITISH JOURNAL OF NUTRITION, (APR 2005) Vol. 93, Supp. [1], pp. S91-
S98.
ISSN: 0007-1145. 2005
Consumption of chicory fructans and probiotireduces cancer risk
biomarkers in colon cancer and polypectomized human subjects.
Van loo J (Reprint); Bosscher D; Caderni G; Collins J K; Pool-Zobel B;
Rowland I; Watzl B; Rafter J
CYA Belgium; Italy; Ireland; Germany; North Ireland; Sweden
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, (NOV 2005) Vol.
14, No. 11,
Part 2, Supp. [S], pp. 2723S-2724S. 2005
Markers to measure immunomodulation in human nutrition intervention
studies Albers R; Antoine J M; Bourdet-Sicard R; Calder P C; Gleeson M;
Lesourd B; Samartin S (Reprint); Sanderson I R; Van loo J; Vas Dias F W;
Watzl BCYA Belgium; Netherlands; France; England; Germany BRITISH
JOURNAL OF NUTRITION, (SEP 2005) Vol. 94, No. 3, pp. 452-481. 2005
4. Gut fermentation products of inulin-derived prebiotibeneficially
modulate markers of tumour progression in human colon tumour cells
Klinder, Annett; Gietl, Eva; Hughes, Roisin; Jonkers, Nadine; Karlsson,
Pernilla; McGlyn, Hugh; Pistoli, Stella; Tuohy, Kieran; Rafter, Joseph;
Rowland, Ian R.; van loo, Jan; Pool-Zobel, Beatrice L.
Department of Nutritional Toxicology, Institute for Nutrition, Friedrich
Schiller University, Jena, D-07743, Germany
International Journal of Cancer Prevention (2004), 1(1), 19-32
CODEN: IJCPC6; ISSN: 1554-1134 2004
Synbiotic consumption modulates cancer risk biomarkers in colon cancer
and
polypectomised human subjects.
Clune Y (Reprint); Meaney K; O'Donoghue M; Klinder A; May M; Roller M;
Karlsson P; Hughes R; Jonkers N; Salvadori M; Bennett M; O'Riordan M;
Dunne C; O'Sullivan G; van loo J; Rechkemmer G; Rafter J; Watzl B;
Caderni G; Rowland I; Pool-Zobel B L; Collins J K
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, (NOV 2004) Vol.
13, No. 11,
Part 2, pp. 1828S-1829S. 2004
Synergy1: Orafti's second generation chicory fructan with significantly
enhanced nutritional properties
van loo, Jan
ORAFTI, Tienen, Belg.
Agro Food Industry Hi-Tech (2004), 15(6), 6-8 2004
Dietary modulation of the human colonic microbiota: updating the concept
of prebiotics
Gibson, Glenn R.; Probert, Hollie M.; van loo, Jan; Rastall, Robert A.;
Roberfroid, Marcel B.
Nutrition Research Reviews (2004), 17(2), 259-275 2004
The specificity of the interaction with intestinal bacterial fermentation
by prebiotidetermines their physiological efficacy
Van loo J (Reprint)
ORAFTI, Aandorenstr 1, B-3300 Tienen, Belgium (Reprint); ORAFTI, B-3300
Tienen, Belgium
Jan.Van.Loo@orafti.com
CYA Belgium
NUTRITION RESEARCH REVIEWS, (JUN 2004) Vol. 17, No. 1, pp. 89-98. 2004
PASSCLAIM-diet-related cancer
Rafter, Joseph; Govers, Mirjam; Martel, Paule; Pannemans, Daphne;
Pool-Zobel, Beatrice; Rechkemmer, Gerhard; Rowland, Ian; Tuijtelaars,
Sandra; van loo, Jan
European Journal of Nutrition (2004), 43(Suppl. 2), II/47-II/84 2004
Prebiotipromote good health: The basis, the potential, and the emerging
evidence
Van loo J A E (Reprint)
JOURNAL OF CLINICAL GASTROENTEROLOGY, (JUL 2004) Vol. 38, No. 6,
Supp.
[S], pp. S70-S75. 2004
5. Prebiotic treatment modulates the gut-associated immune system and
decreases AOM-induccd colon carcinogenesis in F344 rats.
Roller M (Reprint); Femia P; Caderni G; Rechkemmer G; Van Loo J; Watzl B
CYA Germany; Italy; Belgium
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, (NOV 2003) Vol.
12, No. 11,
Part 2, Supp. [S], pp. 1335S-1335S. 2003
Nutritional responses to the presence of inulin and oligofructose in the
diets of domesticated animals: a review
Flickinger, Elizabeth A.; Van loo, Jan; Fahey, George C., Jr.
Critical Reviews in Food Science and Nutrition (2003), 43(1), 19-60 2003
Prebiotic Synergy1 and Sulindac, a nonsteroidal anti-inflammatory drug:
Effect on azoxymethane-induced aberrant crypt foci in Fisher rats.
Verghese M (Reprint); Bonsi I A; Walker L T; Shackelford L; Chawan C B;
Van loo J
JOURNAL OF NUTRITION, (NOV 2003) Vol. 133, No. 11, Supp. [1], pp.
3854S-3854S. 2003
A population-based study of glutathione S-transferase M1, T1 and P1
genotypes and risk for lung cancer
Nazar-Stewart V (Reprint); Vaughan T L; Stapleton P; Van loo J;
Nicol-Blades B; Eaton D L
LUNG CANCER, (JUN 2003) Vol. 40, No. 3, pp. 247-258.
ISSN: 0169-5002. 2003
Molecular biological methods for studying the gut microbiota: The EU
human
gut flora project
Blaut, M.; Collins, M. D.; Welling, G. W.; Dore, J.; Van loo, J.; De
Vos, W.
British Journal of Nutrition (2002), 87(Suppl. 2), S203-S211 2002
Inhibitory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on
azoxymethane-induced aberrant crypt foci in rats is enhanced by Synergy
1.
Verghese M (Reprint); Walker L T; Richardson J E W; Bonsi I A;
Shackelford
L; Chawan C B; Van loo J
Alabama A&M Univ, Normal, AL 35762 USA; ORAFTI, Tienen, Belgium
CYA USA; Belgium
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, (OCT 2002) Vol. 11,
No. 10,
Part 2, pp. 1155S-1155S. MA A213. 2002
Experimental evidences on the potential of prebiotic fructans to reduce
the risk of colon cancer
Pool-Zobel, B.; Van loo, J.; Rowland, I.; Roberfroid, M. B.
British Journal of Nutrition (2002), 87(Suppl. 2), S273-S281 2002
Van loo, J and Jonkers, N (2001) Evaluation in human volunteer of the
potential anticarcinogenic activities of novel nutritional concepts : prebiotics,
probiotiand synbiotics. Nutr. Metab. Cardiovasc. Dis Suppl to No 4, pp. 87-
93 2001
6. Effects of dietary sucrose on hippocampal serotonin release: a
microdialysis study in the freely-moving rat
Smolders, Ilse; Van loo, Jan; Sarre, Sophie; Ebinger, Guy; Michotte,
Yvette
British Journal of Nutrition (2001), 86(2), 151-155 2001
Functional food properties of non-digestible oligosaccharides: a consensus
report from the ENDO project (DGXII AIRII-CT94-1095)
Van loo, Jan; Cummings, John; Delzenne, Nathalie; Englyst, Hans; Franck,
Anne; Hopkins, Mark; Kok, Nadine; MacFarlane, George; Newton,
Dorothy;
Quigley, Michael; Roberfroid, Marcel; Van Vliet, Trinette; Van Den
Heuvel,
Ellen
ORAFTI, Tienen, B3300, Belg.
British Journal of Nutrition (1999), 81(2), 121-132 1999
Roberfroid,M. B.; Van loo,J. & Gibson,G. R. (1998) The bifidogenic nature of
chicory inulin and its hydrolysis products Journal of Nutrition, vol. 128(1);
pp. 11-19. 1998
Van loo,J. (1998) Potential health benefits of non-digestible oligosaccharide
Lebensmittel-Technologie, vol. 31(5); pp. 162-168. 1998
On the presence of inulin and oligofructose as natural ingredients in the
Western diet
Van loo, Jan; Coussement, Paul; De Leenheer, Leen; Hoebregs, Hubert;
Smits, Georges
Critical Reviews in Food Science and Nutrition (1995), 35(6), 525-52 1995
Dietary fiber inulin and oligofructose as food ingredients
Van loo, J.
Tienen, B-3300, Belg.
Voeding (1995), 56(4), 6-9 1995
Non-digestible oligosaccharides and bifidobacteria - implications for
health
Gibson, Glenn R.; Willis, Caroline L.; Van loo, Jan
Med. Res. Council, Dunn Clinical Nate. Cen., Cambridge, UK
International Sugar Journal (1994), 96(1150), 381-7 1994
The identification by proton and carbon-13 NMR spectroscopy of sucrose,
1-kestose, and neoketose in mixtures present in plant extracts
De Bruyn, Andre; Van loo, Jan
Carbohydrate Research (1991), 211(1), 131-6 1991
Characteristiof pectins extracted from sugar-beet pulp by Geotrichum
penicillatum
Ralet, Marie Christine; Thibault, J. F.; Hallaert, J.; Vandamme, E.; Van
Loo, J.
Sciences des Aliments (1990), 10(4), 865-76 1990
7. Nutritional, physiological and process-technological improvements of the
xanthan fermentation process
De Vuyst, L.; Vermeire, A.; Van loo, J.; Vandamme, E. J.
Fac. Agric. Sci., State Univ. Ghent, Ghent, 9000, Belg.
Mededelingen van de Faculteit Landbouwwetenschappen, Universiteit Gent
(1987), 52(4B), 1881-900 1987
Microbial sucrose phosphorylase: fermentation process, properties, and
biotechnical applications
Vandamme, Erick J.; Van loo, Jan; Machtelinckx, Lieve; De Laporte, Andre
Advances in Applied Microbiology (1987), 32, 163-201 1987
Optimization of sucrose phosphorylase production by Leuconostoc
mesenteroides
Vandamme, Erick J.; Van loo, Jan; Simkens, Eric; De Laporte, Andre
Journal of Chemical Technology and Biotechnology (1987), 39(4), 251-62 1987
Two-step fermentation process for improved xanthan production by
Xanthomonas campestris NRRL-B-1459
De Vuyst, Luc; Van loo, Jan; Vandamme, Erick J.
Journal of Chemical Technology and Biotechnology (1987), 39(4), 263-73 1987
Dynamiand regulation of sucrose phosphorylase formation in Leuconostoc
mesenteroides fermentations
Vandamme, E. J.; Van loo, J.; De Laporte, A.
Biotechnology and Bioengineering (1987), 29(1), 8-15 1987
Leuconostoc mesenteroides sucrose phosphorylase: improved fermentation
process, immobilization, and applications
Vandamme, E. J.; Van loo, J.; Machtelinckx, L.; Simkens, E.; De Laporte,
A.
Eur. Congr. Biotechnol., 3rd (1984), Volume 1, 333-8 Publisher: Verlag 1984